Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

Robert G. Hart, Mukul Sharma, Hardi Mundl, Ashkan Shoamanesh, Scott E. Kasner, Scott D. Berkowitz, Guillaume Pare, Bodo Kirsch, Janice Pogue, Calin Pater, Gary Peters, Antoni Davalos, Wilfried Lang, Yongjun Wang, Yilong Wang, Luis Cunha, Jens Eckstein, Turgut Tatlisumak, Nikolay Shamalov, Robert MikulikPablo Lavados, Graeme J. Hankey, Anna Czlonkowska, Danilo Toni, Sebastian F. Ameriso, Rubens J. Gagliardi, Pierre Amarenco, Daniel Bereczki, Shinichiro Uchiyama, Arne Lindgren, Matthias Endres, Raf Brouns, Byung-Woo Yoon, George Ntaios, Roland Veltkamp, Keith W. Muir, Serefnur Ozturk, Antonio Arauz, Natan Bornstein, Alan Bryer, Martin J. O'Donnell, Jeffrey Weitz, Frank Peacock, Ellison Themeles, Stuart J. Connolly

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences